New agents in the treatment of CLL.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn , Issue , 2008, Pages 457-464

  O'Brien, Susan ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY; PROTEIN BCL 2;

ARTICLE; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CLASSIFICATION; CLINICAL TRIAL; DRUG ANTAGONISM; HUMAN; IMMUNOLOGY; PATHOLOGY;

ALKYLATING AGENTS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; IMMUNOLOGIC FACTORS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; NEOPLASM STAGING; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 67649253580     PISSN: 15204391     EISSN: None     Source Type: Journal    
DOI: 10.1182/asheducation-2008.1.457     Document Type: Article

References (0)